|
Match
|
Document |
Document Title |
|
|
7615230 |
Method for decreasing sebum production
The present invention is directed to the topical application of the malonamide ACAT inhibitors described by Formula I. Other aspects of the invention are directed to topical formulations of these...
|
|
|
7592358 |
Alkyne compounds with MCH antagonistic activity and medicaments comprising these compounds
Alkyne compounds having MCH-receptor antagonistic activity, which are useful for preparing pharmaceutical compositions for the treatment of metabolic disorders and/or eating disorders, particularly...
|
|
|
7572819 |
Compounds which potentiate glutamate receptor and uses thereof in medicine
Compounds of formula (I) or a pharmaceutically acceptable salt, solvate or prodrug thereof, are disclosed:
wherein R 1 is C 1-6 alkyl, haloC 1-6 alkyl, C 2-6 alkenyl, amino, monoC 1-4...
|
|
|
7572818 |
2-pyridylethylbenzamide derivative
Compound of general formula (I) in which p is an integer equal to 1, 2, 3 or 4; q is an integer equal to 1, 2, 3, 4 or 5; each substituent X is chosen, independently of the others, as being...
|
|
|
7566738 |
Acyloxyalkyl carbamate prodrugs of sulfinic acids, methods of synthesis, and use
Acyloxyalkyl carbamate prodrugs of 3-aminopropylsulfinic acid and analogs thereof, pharmaceutical compositions of 3-aminopropylsulfinic acid and analogs thereof, methods of making prodrugs of...
|
|
|
RE40861 |
Compounds having reversible inhibiting activity of carnitine palmitoyl-transferase
Compounds of formula (I)
wherein the groups are as defined in the description are disclosed.
The compounds of formula (I) are endowed with reversible inhibiting activity of carnitine...
|
|
|
7560474 |
Derivatives of pyridilethanol (phenylethyl) amines as inhibitors of cholesterol biosynthesis, process for their preparation and pharmaceutical compositions containing them
The novel derivatives of pyridilethanol (phenylethyl) amines of formula I
are described wherein n is an integer from 1 to 4, R 1 is a hydrogen atom, hydroxyl group or lower C 1-6 alkoxy group...
|
|
|
7560122 |
Pharmaceutical dosage form bearing pregnancy-friendly indicia
A pharmaceutical dosage form comprising at least one active ingredient and destined for administration to pregnant women. The pharmaceutical dosage form bears pregnancy-friendly indicia apt to...
|
|
|
7557132 |
Compounds useful as pesticides
Compounds useful to control pests are provided.
|
|
|
7550497 |
Phosphoramide derivatives
New phosphoramide derivatives of formula (I) and the salts and solvates thereof, wherein the meanings of the various substituents are as disclosed in the description. Said compounds are useful as...
|
|
|
7550490 |
Benzamide derivatives as histone deacetylase inhibitors with potent differentiation and anti-proliferation activity
The present invention is related to the preparation and pharmaceutical use of novel benzamide derivatives as defined in the specification of formula (I) as histone deacetylase inhibitors (HDACI),...
|
|
|
7547731 |
Formamide derivatives for the treatment of diseases
The invention relates to compounds of formula (1)
and to processes for the preparation of, intermediates used in the preparation of, compositions containing and the uses of, such derivatives....
|
|
|
7547716 |
Sulfonamide derivatives
A medicament for enhancing an effect of a cancer therapy based on a mode of action of DNA injury, which comprises as an active ingredient a compound represented by the general formula (I) or a...
|
|
|
7547701 |
Haloalkyl containing compounds as cysteine protease inhibitors
The present invention is directed to compounds that are inhibitors of cysteine proteases, in particular, cathepsins B, K, L, F, and S and are therefore useful in treating diseases mediated by these...
|
|
|
7547444 |
Methods for controlling fungi and bacteria
The present invention includes compounds of pyridinium salts and methods of their use for agricultural purposes. The present invention also relates to methods of controlling fungi and/or bacteria.
|
|
|
7538127 |
Medicinal compounds
A compound of formula (I) or a salt, solvate, or physiologically functional derivative thereof, wherein: m is an integer of from 2 to 8; n is an integer of from 2 to 5; with the proviso that m+n is...
|
|
|
7531695 |
Therapeutic agents for the treatment of cancer, metabolic diseases and skin disorders
The present invention is directed to compounds having the structure (I) wherein R 1 , R 2 , R 3 , R 4 , R 5 and m are as defined herein. The compounds of this invention are novel therapeutic...
|
|
|
7531538 |
α- and β-Amino acid hydroxyethylamino sulfonamides useful as retroviral protease inhibitors
α- and β-amino acid hydroxyethylamino sulfonamide compounds are effective as retroviral protease inhibitors, and in particular as inhibitors of HIV protease.
|
|
|
7528170 |
Sulfonamide derivatives for the treatment of diseases
The invention relates to compounds of formula (1)
and to processes for the preparation of, intermediates used in the preparation of, compositions containing and the uses of, such derivatives....
|
|
|
7521461 |
Benzoic acid derivatives as modulators of PPAR alpha and gamma
A compound of formula (I) wherein R 1 represents aryl optionally substituted by a heterocyclic group or a heterocyclic group optionally substituted by aryl wherein each aryl or heterocyclic group...
|
|
|
7521062 |
Thiosemicarbazones as anti-virals and immunopotentiators
The present invention is directed to novel immune potentiators, novel vaccine adjuvants, novel compounds and pharmaceutical compositions, novel methods for treating viral infections, including HCV,...
|
|
|
7517880 |
Inhibition of p38 kinase using symmetrical and unsymmetrical diphenyl ureas
This invention relates to the use of a group of aryl ureas in treating cytokine mediated diseases and proteolytic enzyme mediated diseases, and pharmaceutical compositions for use in such therapy.
|
|
|
7517535 |
Non-systemic control of parasites
Use of agonists and antagonists of the nicotinergic acetylcholine receptors of insects for the non-systemic control of parasitic insects, such as fleas, lice and flies, on humans and on animals.
|
|
|
7501541 |
Malonamides as orexin antagonists
The present invention relates to compounds of formula I
wherein
Ar 1 , Ar 2 , R, R 1 , R 2 , R 3 and n are as defined herein or to pharmaceutically suitable acid addition salts, optically...
|
|
|
7498358 |
Human ADAM-10 inhibitors
The present invention provides compounds useful for inhibiting the ADAM-10 protein. Such compounds are useful in the in vitro study of the role of ADAM-10 (and its inhibition) in biological...
|
|
|
7495001 |
Benzannelated derivatives, their manufacture and use as pharmaceutical agents
There are presented compounds of the formula
wherein R 6 and R 7 is
R 4 and R 5 or R 5 and R 6 together with the carbon atoms to which they are attached, form a ring as...
|
|
|
7491739 |
TNF-α production inhibitors
A purpose of the present invention is to provide TNF-α production inhibitors being useful as therapeutic agents for autoimmune diseases such as rheumatoid arthritis. Novel compounds having the...
|
|
|
7488848 |
Alpha ketoamide compounds as cysteine protease inhibitors
The present invention is directed to compounds that are inhibitors of cysteine proteases, in particular, cathepsins B, K, L, F, and S and are therefore useful in treating diseases mediated by these...
|
|
|
7482491 |
Amino alcohol derivative, addition salt thereof, and immunosuppressant
An amino alcohol derivative represented by the following general formula (1) (for example, (±)-2-amino-5-[4-(3-benzyloxyphenylthio)-2-chlorophenyl]-2-
methylpentane-1-ol) exhibits strong...
|
|
|
7482369 |
Anthranilic acid amides and their use as VEGF receptor tyrosine kinase inhibitors
The invention relates to anthranilic acid amide derivatives of formula I,
wherein R 1 represents H or lower alkyl, R 2 represents H or lower alkyl, R 3 represents perfluoro lower alkyl,...
|
|
|
7479491 |
Azanthranylalkyl and -cycloalkyl amides and their use as VEGF receptor inhibitors
The invention relates to substituted anthranylalkyl and -cycloalkyl amides of general formula (I) and to their use as medicaments for treating diseases caused by persistent angiogenesis.
|
|
|
7476763 |
Oxo-substituted cyclohexyl-1,4-diamine compounds
Novel cyclohexyl-1,4-diamine compounds corresponding to formula I:
methods for their production, pharmaceutical formulations containing these compounds, methods of producing such pharmaceutical...
|
|
|
7476683 |
Glycinamide derivatives as raf-kinase inhibitors
The present invention relates to glycinamide derivatives of formula (I), the use of the compounds of formula (I) as inhibitors of raf-kinase, the use of the compounds of formula (I) for the...
|
|
|
7468383 |
Proteasome inhibitors and methods of using the same
The present invention provides boronic acid compounds, boronic esters, and compositions thereof that can modulate apoptosis such as by inhibition of proteasome activity. The compounds and...
|
|
|
7465748 |
Amide derivative
There is provided a pharmaceutical drug, particularly a novel compound useful for prophylaxis or a therapeutic treatment of various diseases involving infections with viruses of the herpesvirus...
|
|
|
7459470 |
N-oxide anthranylamide derivatives and their use as medicaments
Substituted N-oxidanthranilamide derivatives, their production and use as pharmaceutical agents for treating diseases that are triggered by persistent angiogenesis are described. The compounds...
|
|
|
7459468 |
Aryl sulfonic pyridoxines as antiplatelet agents
Aryl sulfonic pyridoxine compounds with antiplatelet aggregation characteristics for the treatment of cardiovascular and cardiovascular related disease, are described. The methods are directed to...
|
|
|
7456179 |
Methods of treating ischemic related conditions
The present invention relates to methods of treating ischemia-related conditions by administering to a patient in need of such methods certain thiosemicarbazone compounds. Preferred embodiments of...
|
|
|
7435729 |
Compounds and methods for modulation of estrogen receptors
Compounds that modulate the estrogen receptor (ER) are disclosed, as well as pharmaceutical compositions containing the same. In a specific embodiment, the compounds are selective modulators for...
|
|
|
7429604 |
Six-membered heterocycles useful as serine protease inhibitors
The present invention provides compounds of Formula (I):
or a stereoisomer or pharmaceutically acceptable salt or solvate form thereof, wherein the variables A, L, Z, X 1 , X 2 , X 3 , X 4 ,...
|
|
|
7429593 |
Utilities of amide compounds
Compounds having an activity to enhance the expression of apoAI are provided, which are used as medicaments. Compounds of formula (I):
in which ring A and Ar 1 are independently a monocyclic...
|
|
|
7429592 |
Cyanoanthranilamide derivatives and the use thereof as medicaments
Substituted cyanoanthranilamide derivatives, their production and use as pharmaceutical agents for treating diseases that are triggered by persistent angiogenesis are described. The compounds...
|
|
|
7423170 |
Anticancer agents based on regulation of protein prenylation
Oncoproteins such as Ras and RhoB are known to induce cell division in an unrestrained manner when such proteins are localized at the inner surface of a cancer cell membrane. The localization is...
|
|
|
7423067 |
Diphenyl cyclopentyl amides as cannabinoid-1 receptor inverse agonists
Novel compounds of structural formula (I) are antagonists and/or inverse agonists of the Cannabinoid-1 (CB1) receptor and are useful in the treatment, prevention and suppression of diseases...
|
|
|
7423012 |
Phosphinyloxy, oxime and carboxylic acid derivatives which are useful as carboxypeptidase U inhibitors
The present invention relates to compounds of Formula I, and pharmaceutically acceptable salts or solvates thereof, or solvates of such salts,
which compounds inhibit carboxypeptidase U and...
|
|
|
7420000 |
Amino phosphonate and amino bis-phosphonate derivatives
Aminophosphonate and amino bisphosphonate compounds and methods for their preparation are provided. Also provided are pharmaceutical and agricultural compositions containing the compounds. The...
|
|
|
7419967 |
Sulfonamide inhibitors of aspartyl protease
The present invention relates to a novel class of sulfonamides which are aspartyl protease inhibitors. In one embodiment, this invention relates to a novel class of HIV aspartyl protease inhibitors...
|
|
|
7417060 |
Aminoalcohol derivatives
The present invention relates to a compound formula[I]:
wherein
X is bond, —CH 2 —, —O— or —NH—, R 1 and R 12 are each independently hydrogen, halogen, lower alkyl, etc., R 2 ...
|
|
|
7417059 |
Substituted aromatic-ring compounds, process for producing the same and use
The present invention is directed to a class of cyclohexene derivatives bearing sulfamoyl and ester groups which have an inhibitory activity on nitric oxide (NO) production and cytokine production,...
|
|
|
7414064 |
4-(3,3-dihalo-allyloxy) phenoxy alkyl derivatives
Compounds of formula
wherein A 1 , A 2 and A 3 are each independently of the others a bond or a C 1 -C 6 alkylene bridge; A 4 is a C 1 -C 6 alkylene bridge; D is CH or N; W is, for...
|